30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Merdad Parsey

Track

Insider profile

Currently holds a position at Gilead Sciences Inc

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Gilead Sciences Inc Nov. 1, 2019 -
Merdad Parsey's trades of Gilead Sciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-03 2025-03-03
PrS Proposed sale
2,501
321.73
US$4,345,044 		2,501 321.73 US$4,345,044
2025-01-31 2025-01-31
PrS Proposed sale
11,506
163.27
US$4,157,703 		11,506 163.27 US$4,157,703
2024-11-29 2024-11-27
S Sale
18,462 -18.3%
270.45
US$4,179,125 		18,462 -18.3% 270.45 US$4,179,125
2024-11-29 2024-11-27
S Sale
3,199 -3.4%
91.80
US$293,679 		3,199 -3.4% 91.80 US$293,679
2024-11-29 2024-11-27
S Sale
5,200 -5.2%
91.80
US$477,381 		5,200 -5.2% 91.80 US$477,381
2024-11-29 2024-11-27
S Sale
88,119 -46.9%
92.00
US$8,106,948 		88,119 -46.9% 92.00 US$8,106,948
2024-11-29 2024-11-27
S Sale
57,294 -23.4%
91.79
US$5,259,297 		57,294 -23.4% 91.79 US$5,259,297
2024-11-27 2024-11-27
PrS Proposed sale
164,211
91.92
US$15,094,008 		164,211 91.92 US$15,094,008
2024-11-07 2024-11-06
PlS Planned sale
5,000 -4.8%
91.50
US$457,500 		5,000 -4.8% 91.50 US$457,500
2024-11-07 2024-11-06
PlS Planned sale
20,590 -16.4%
91.50
US$1,883,985 		20,590 -16.4% 91.50 US$1,883,985
2024-11-06 2024-11-06
PrS Proposed sale
25,590
91.50
US$2,341,485 		25,590 91.50 US$2,341,485
2024-10-02 2024-10-01
PlS Planned sale
2,000 -2.0%
83.83
US$167,660 		2,000 -2.0% 83.83 US$167,660
2024-10-01 2024-10-01
PrS Proposed sale
2,000
83.83
US$167,660 		2,000 83.83 US$167,660
2024-09-13 2024-09-12
PlS Planned sale
21,246 -17.2%
84.50
US$1,795,287 		21,246 -17.2% 84.50 US$1,795,287
2024-09-12 2024-09-12
PrS Proposed sale
21,246
84.50
US$1,795,287 		21,246 84.50 US$1,795,287
2024-07-01 2024-07-01
PrS Proposed sale
2,000
68.63
US$137,260 		2,000 68.63 US$137,260
2024-07-01 2024-07-01
PlS Planned sale
2,000 -2.0%
68.63
US$137,260 		2,000 -2.0% 68.63 US$137,260
2024-04-02 2024-04-01
PlS Planned sale
2,000 -2.0%
72.96
US$145,920 		2,000 -2.0% 72.96 US$145,920
2024-04-01 2024-04-01
PrS Proposed sale
2,000
72.96
US$145,920 		2,000 72.96 US$145,920
2024-02-29 2024-02-29
PrS Proposed sale
8,230
72.74
US$598,623 		8,230 72.74 US$598,623
2024-02-29 2024-02-29
PlS Planned sale
8,230 -8.2%
72.74
US$598,624 		8,230 -8.2% 72.74 US$598,624
2024-02-29 2024-02-28
PlS Planned sale
2,000 -1.9%
73.18
US$146,360 		2,000 -1.9% 73.18 US$146,360
2024-02-28 2024-02-28
PrS Proposed sale
2,000
73.18
US$146,360 		2,000 73.18 US$146,360
2023-09-13 2023-09-12
PlS Planned sale
1,501 -2.1%
76.99
US$115,562 		1,501 -2.1% 76.99 US$115,562
2023-09-12 2023-09-12
PrS Proposed sale
1,501
76.99
US$115,562 		1,501 76.99 US$115,562
2023-06-14 2023-06-13
PlS Planned sale
1,485 -4.8%
76.90
US$114,196 		1,485 -4.8% 76.90 US$114,196
2023-06-13 2023-06-13
PrS Proposed sale
1,485
76.90
US$114,196 		1,485 76.90 US$114,196
2023-03-14 2023-03-13
PlS Planned sale
6,126 -8.0%
78.99
US$483,893 		6,126 -8.0% 78.99 US$483,893
2023-03-02 2023-03-01
PlS Planned sale
12,984 -15.6%
79.96
US$1,038,225 		12,984 -15.6% 79.96 US$1,038,225
2023-01-03 2022-12-30
PlS Planned sale
553 -1.2%
85.33
US$47,187 		553 -1.2% 85.33 US$47,187
2020-08-19 2020-08-17
PlS Planned sale
182 -100.0%
68.32
US$12,434 		182 -100.0% 68.32 US$12,434